Dr. Jörk Zwicker
Member of the Board
Member of the Board
Dr. Jörk Zwicker
Dr. Jörk Zwicker has a technical background in chemistry and biology and is a senior partner at Zwicker Schnappauf & Partner (ZSP) Patentanwälte PartG mbB. For more than 25 years, he has been advising both start-up companies and large corporations on the strategic development, defense and enforcement of their intellectual property rights, in particular patents for biological agents such as Praluent®, Dupixent®, Toujeo®, Altuvoct®, Gohibic® and Enjaymo®. In the strategic development of product-relevant intellectual property portfolios, Dr. Zwicker’s focus is on life cycle management and the interaction between patent and regulatory law. Dr. Zwicker is also Chief Legal Officer of Eisbach Bio GmbH. Dr. Jörk Zwicker was elected to the MetrioPharm AG Board of Directors for a three-year term at the Extraordinary General Meeting held on April 17, 2025.